Sutro Biopharma
STRO
STRO
50 hedge funds and large institutions have $128M invested in Sutro Biopharma in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.67% more ownership
Funds ownership: 47.48% → 49.15% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
50
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$4.69M | |
| 2 | +$1.33M | |
| 3 | +$730K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$598K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$496K |
Top Sellers
| 1 | -$2.25M | |
| 2 | -$1.07M | |
| 3 | -$1.02M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$172K |
| 5 |
Morgan Stanley
New York
|
-$99.2K |